Paolo Teston appointed FDA director general

Malacañang confirmed on Friday the appointment of Health Undersecretary Paolo Teston as the new director general of the Food and Drug Administration (FDA).

In a press release, Teston expressed his mission to restore public trust in the FDA and bring it to new heights through professionalism, integrity, and efficiency.

He plans to conduct a thorough review of the agency's core operations, including inspection, licensing, and monitoring, to ensure health product safety, with reforms that will be swift, strategic, and anchored on concrete results.

Teston also pledged to improve job security, professional growth, and working conditions for FDA employees as part of his commitment to their welfare.

Prior to his appointment, Teston led the Health Regulation and Facility Development Cluster (HRFDC) of the DOH, which includes the Health Facility Development Bureau, the Health Facilities and Services Regulatory Bureau, and the Bureau of Quarantine.